Analyst Meet / AGM     30-Jan-19
Conference Call
Ion Exchange
Order backlog as on Dec 18 is around Rs 975 crore excluding the Srilankan order
In interaction with Mr. Ankur Patni Executive Director on 30 Jan 19

Key Highlights

In engineering segment, momentum will continue. Present order backlog has better margin portfolio and expects the margins to sustain going forward

Revenue recognition of Srilankan order was not strong in Dec 18 quarter as some dispatches got shifted to coming quarter. Rs 47 crore revenue recognized so far in 9 months ended Dec 18. Around Rs 150 crore net sales expected in Mar 19 quarter.

On Srilankan orders, Rs 246 crore so far is recognized in past 18 months, Rs 150 crore will be recognized in Mar 19 and rest around Rs 800-850 crore will be recognized in FY 20.

Some dispatches plan got delayed in Srilanan order due to deferrement from customer end to Jan 19. No delay from company side.

The company has started the exercise of dematerialising of Promoters shares and is hopeful by March end the company will come out from T2T segment. The company will then start procedure for listing on NSE as well in FY 20.

Order backlog as on Dec 18 is around Rs 975 crore excluding Srilankan order as compared to Rs 550 crore as on Dec 17.

Bid pipeline is around Rs 5000 crore in engineering segment. Strong order momentum exists.

Current turmoil in international market makes more business opportunities for the company in engineering segment.

Competitive landscape in global market improved in company's favour. Overall it should continue to favour going forward as well.

Net debt as on Dec 18 stood at Rs 105 crore.

Higher volumes and control on costs resulted in improvement in margins in consumer segment. The company would continue to expand in rural and institutional segment.

Consolidated numbers should see improvement and losses of subsidiaries will come down further. Expects some subsidiaries will breakeven in FY 20 while some more time will be required for the break even of all the subsidiaries.

There is some seed money still being put in each of these subsidiaries and progressive improvements are visible.

Growth in chemical segment is largely due to improvement in exports. Capacity utilization at around 70%. Expects double digit growth to continue in this segment.

Rs 40 crore capex for FY 19 including the Resin expansion so far spent round Rs 25 crore.

Previous News
  Nifty trades near 24,100 level; IT shares rally for 3rd day
 ( Market Commentary - Mid-Session 01-Jul-24   11:37 )
  Board of Ion Exchange (India) recommends final dividend
 ( Corporate News - 30-May-24   10:58 )
  Ion Exchange (India) secures a contract worth Rs 343.36 cr
 ( Corporate News - 02-Dec-22   19:08 )
  Ion Exchange rises on bagging order worth Rs 168-cr
 ( Hot Pursuit - 09-Sep-24   10:11 )
  Ion Exchange
 ( Results - Analysis 26-May-18   07:22 )
  Ion Exchange (India) soars after Nippon MF ups stake
 ( Hot Pursuit - 01-Jul-24   11:07 )
  Ion Exchange (India) to conduct board meeting
 ( Corporate News - 31-Mar-23   10:23 )
  Ion Exchange (India) consolidated net profit rises 127.24% in the September 2019 quarter
 ( Results - Announcements 26-Oct-19   10:29 )
  Wockhardt Ltd leads gainers in 'A' group
 ( Hot Pursuit - 01-Jul-24   12:00 )
  Ion Exchange (India) consolidated net profit rises 69.13% in the December 2022 quarter
 ( Results - Announcements 03-Feb-23   17:29 )
  ION Exchange spurts after Q4 PAT rises 18% YoY to Rs 83 cr
 ( Hot Pursuit - 30-May-22   12:25 )
Other Stories
  MAS Financial Services
  21-Sep-24   17:18
  Motherson Sumi Wiring India
  22-Aug-24   17:22
  SKF India
  22-Aug-24   15:34
  Gabriel India
  16-Aug-24   16:01
  Cantabil Retail India
  14-Aug-24   19:26
  Fiem Industries
  14-Aug-24   16:54
  Senco Gold
  14-Aug-24   11:25
  Advanced Enzymes Technologies
  14-Aug-24   09:45
  Pennar Industries
  14-Aug-24   09:07
  RVNL
  14-Aug-24   09:06
Back Top